Company Filing History:
Years Active: 2022
Title: Michael David Bengt Fenster: Innovator in Pharmaceutical Chemistry
Introduction
Michael David Bengt Fenster is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes in drug preparation. His work is recognized for its potential impact on the development of new therapeutic agents.
Latest Patents
Michael holds a patent for a process titled "Process for the preparation of N-((1R,2S,5R)-5-(-butylamino)-2-((S)-3-(7--butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrroldin-1-yl)cyclohexyl)acetamide." This invention relates to an improved method for synthesizing a specific compound that may have therapeutic applications. He has 1 patent to his name, showcasing his innovative approach to pharmaceutical development.
Career Highlights
Michael is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role involves research and development, where he applies his expertise to advance drug discovery and formulation processes. His contributions are vital to the company's mission of delivering innovative medicines to patients.
Collaborations
Michael has collaborated with talented coworkers, including Burcu Selin Aytar and Alina Borovika. These partnerships enhance the research environment and foster innovation within the team.
Conclusion
Michael David Bengt Fenster is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new therapeutic solutions. His patent and contributions at Bristol-Myers Squibb Company reflect his commitment to advancing healthcare through innovation.